Sartorius Stedim Biotech S.A. buy Barclays PLC
Start price
06.01.26
/
50%
€218.80
Target price
06.01.27
-
Performance (%)
-13.12%
Price
15.07.26
€189.40
Summary
This prediction is currently active. The prediction for Sartorius Stedim Biotech S.A. disappoints with a performance of -13.12%. A total of €0.69 was paid as dividends for this prediction. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius Stedim Biotech S.A. | 8.477% | 8.477% |
| iShares Core DAX® | -0.097% | 0.537% |
| iShares Nasdaq 100 | 0.585% | -2.390% |
| iShares Nikkei 225® | -0.055% | -2.746% |
| iShares S&P 500 | 0.939% | 1.287% |
Comments by Barclays_PLC for this prediction
In the thread Sartorius Stedim Biotech S.A. diskutieren
Sartorius Stedim Biotech (OTCMKTS:SDMHF) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for SDMHF provided by MarketBeat